Keith Harmon, MD
Pulmonary Disease · St Louis Park, MNNPI 1003892860
Payments from drug & device makers
Across 4 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Itamar Medical Inc$46
- Philips North America LLC$23
What the payments were for
- Food & beverage$69100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Itamar Medical Inc | 2 | $46 |
| Philips North America LLC | 2 | $23 |
How this compares
$69 in reported general payments places this provider in the 35th percentile of 261 pulmonary disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 43 | $499,797 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 331 | $253,915 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 189 | $109,362 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 132 | $71,896 |
| Breo ElliptaFluticasone/Vilanterol | 111 | $59,983 |
| Advair HfaFluticasone Propion/Salmeterol | 105 | $50,786 |
| Incruse ElliptaUmeclidinium Bromide | 77 | $38,800 |
| Spiriva RespimatTiotropium Bromide | 39 | $36,272 |
| Arnuity ElliptaFluticasone Furoate | 61 | $15,709 |
| Fluticasone Propionate HfaFluticasone Propionate | 31 | $14,357 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 35 | $12,812 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 57 | $9,252 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $8,781 |
| DuleraMometasone/Formoterol | 20 | $7,979 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $7,265 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in St Louis Park
- Charlene McEvoySaint Paul$8.4M
- Ulrich SpecksRochester$2.6M
- Teng MouaRochester$2.4M
- Hyun KimMinneapolis$1.5M
- Joanne BillingsMinneapolis$1.5M
- Vivek IyerRochester$1.2M
- Timothy AksamitRochester$982K
- Patrick WrightMinneapolis$817K
- Jonathan HovdaMinneapolis$713K
- Kevin GrullonMinneapolis$618K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.